TIRIBUZI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 1.606
NA - Nord America 1.532
AS - Asia 518
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.662
Nazione #
US - Stati Uniti d'America 1.527
UA - Ucraina 395
IE - Irlanda 322
IT - Italia 242
HK - Hong Kong 203
FR - Francia 183
SE - Svezia 134
SG - Singapore 108
VN - Vietnam 107
FI - Finlandia 102
DE - Germania 81
RU - Federazione Russa 80
CN - Cina 70
GB - Regno Unito 21
CH - Svizzera 15
TR - Turchia 9
BE - Belgio 7
UZ - Uzbekistan 7
AT - Austria 6
CZ - Repubblica Ceca 6
KR - Corea 6
PL - Polonia 5
MX - Messico 4
GR - Grecia 3
LB - Libano 3
NL - Olanda 3
CI - Costa d'Avorio 2
ID - Indonesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
MO - Macao, regione amministrativa speciale della Cina 1
SC - Seychelles 1
Totale 3.662
Città #
Chandler 335
Dublin 322
Jacksonville 235
Hong Kong 202
San Mateo 179
Perugia 118
Dong Ket 107
Medford 80
Princeton 80
Singapore 73
Wilmington 61
Ann Arbor 46
Andover 37
Beijing 37
Altamura 33
Lawrence 28
Saint Petersburg 26
Ashburn 23
Helsinki 23
Redmond 18
Des Moines 12
Shanghai 10
Woodbridge 10
Izmir 9
Norwalk 9
Rome 9
Boardman 8
Falls Church 8
Brussels 7
Città Di Castello 7
San Paolo di Civitate 7
Redwood City 6
Seoul 6
Lausanne 4
Moscow 4
New York 4
Simi Valley 4
Brno 3
Detroit 3
Florence 3
Gustavo Adolfo Madero 3
Los Angeles 3
Terni 3
Abidjan 2
Alexandria 2
Auburn Hills 2
Dearborn 2
Den Haag 2
Jakarta 2
Amsterdam 1
Bologna 1
Buffalo 1
Chicago 1
Fairfield 1
Falkenstein 1
Genova 1
Giugliano In Campania 1
Hanover 1
Houston 1
Las Vegas 1
Lilburn 1
London 1
Macao 1
Mahé 1
Menlo Park 1
Mexico City 1
Miami 1
Milan 1
Nanjing 1
Perryton 1
San Diego 1
Sant'ilario D'enza 1
Sondrio 1
Stockholm 1
Tappahannock 1
Tokyo 1
Toronto 1
Velletri 1
Venezia 1
Warsaw 1
Windsor 1
Totale 2.249
Nome #
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 85
Caspase 3 mediated PARP cleavage in lymphocytes from newborn babies of diabetic mothers 84
Beneficial effect of Crocus sativus stigma extract in amyloid-beta degradation by monocytes from sporadic Alzheimer's disease patients 80
Human bone marrow mesenchymal stem cell guidance by a-C:H surface designes 76
Implication of Cathepsins S and D in TPO+IL-16-induced commitment of hematopoietic stem cell differentiation into tolerogenic dendritic cells 75
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 74
miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease 73
beta-NGF and beta-NGF receptor upregulation in blood and synovial fluid in osteoarthritis 72
a-C:H NANOPATTERNED FILM DESIGNS DRIVE HUMAN BONE MARROW MESENCHYMAL STEM CELL CYTOSKELETON ARCHITECTURE 70
Hydrogenated Amorphous Carbon Nanopatterned Film Designs Drive Human Bone Marrow Mesenchymal Stem Cell Cytoskeleton Architecture 70
b-Hexosaminidase and altered cell-mediated immuno-responce 69
Protein Encapsulation in Biodegradable Polymeric Nanoparticles: Morphology, Fluorescence Behaviour and Stem Cell Uptake 68
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 68
Advanced Tools of Regenerative Medicine for Neurodegenerative Diseases 67
a-C:H nanopatterned grooves influence human bone marrow stromal stem cells orientation 64
Alpha and Beta subunits of b-N-acethyl-hexosaminidase are differently regulated during the mammalian brain development: implication for Tay-Sachs disease therapy 63
Caspase 3 activation and PARP cleavage in lymphocytes from newborn babies of diabetic mothers with unbalanced glycaemic control 63
The impact of nitric oxide on calcium homeostasis in PE/CA-PJ15 cells. 61
Tuning multi pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats. 60
B-hexosaminidase isoenzymes and antigen presenting cell function: implication for neurodegenerative process in GM2-gangliosidosis 57
Osteogenic Induction in human Bone Marrow mesenchymal Stem Cells by nonocomposite Scaffold 56
Beta-Hexosaminidase and immuno-response: implications for the neurodegenerative process in GM2 gangliosidosis 56
Beta-Hexosaminidase expression is recapitulated in Neural Stem Cells induced to differentiate and in embryonic to adult brain development in both WT and knock-out mice 56
Crocus sativus L. stigma extract improves amyloid-β degradation mediated by Cathepsin B in monocytes from Alzheimer’s Disease patients 56
Regulation of neural stem cell compartment in a murine model of GM2-gangliosidosis: potential role of EGF and GM3 ganglioside 54
Biodegradable composite porous poly(DL-lactide-co-glycolide) scaffold supports mesenchymal stem cell differentiation and calcium phosphate deposition 54
STEM CELL NICHE AND LYSOSOMAL CATHEPSINS 53
Knock-down of HEXA and HEXB genes correlate with the absence of the immunostimulatory function of HSC-derived dendritic cells 53
Inclusion of multi walled carbon nanotubes on PLLA supports the myogenic differentiation of murine progenitor cells 53
A role for NGF and its receptors TrKA and p75NTR in the progression of COPD 52
Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement theraphy 51
Stem cell niche and lysosomal cathepsins 50
Le cellule staminali stromali di midollo osseo umane sono orientate da nanotopografie di carbonio amorfo idrogenato 50
Biomechanical behaviour of native and sutured bronchi: An in-vitro study 50
MicroRNA mediated lysosomal enzymes down-regulation in cell of peripheral system from aAlzheimer's disease patients 49
MICROPATTERNED HYDROGENATED AMORPHOUS CARBON GUIDES MESENCHYMAL STEM CELLS TOWARDS NEURONAL DIFFERENTIATION 49
La caspasi 3 media l'inattivazione di PARP1 nei linfociti di sangue cordonale provenienti da donne diabetiche 49
Molecular cloning and structural organization of the gene encoding the mouse lysosomal di-N-acetylchitobiase (ctbs) 48
Cathepsin S, Cathepsin D and Cystatin C Balance: an immunomodulator molecular mechanism 48
Mechanotransduction: Tuning Stem Cells Fate 48
Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients 48
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34(+) hematopoietic stem cells of relapsing-remitting multiple sclerosis patients 47
Development of a New Tool for 3D Modeling for Regenarative Medicine 47
Lysosomal hydrolases in Alzheimers and type 2 diabetes mellitus patients 46
Nitric oxide depletion alters hematopoietic stem cell commitment toward immunogenic dendritic cells 46
Specific determination of beta-galactocerebrosidase activity via competitive inhibition of beta-galactosidase 45
Bone marrow stromal cells as a tool for gene/cell therapy for Tay-Sachs disease" 45
Cathepsin S and D expression as a biochemical checkpoint for the generation of tolerogenic dendritic cells from hsc-CD34+ 45
Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology 44
Non-redundant Roles of Cathepsins L, B and S in CD1a+ Dendritic Cells Knocked-down for Cathepsin S by RNA Interference 42
Bone marrow stromal cells as a tool for cell thepaty for lysosomal storage disorders with neurologic involvement 42
Scaffolds nanocompositi contenenti nanoparticelle di idrossiapatite inducono il differenziamento osteogenico delle cellule staminali adulte e delle cellule staminali pluripotenti indotte 42
Efficient siRNA Delivery by the Cationic Liposome DOTAP in Human Hematopoietic Stem Cells Differentiating into Dendritic Cells 42
Enzimi lisosomiali come marcatori della malattia di alzheimer in pazienti affetti da diabete mellito tipo 2 40
Electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nonocomposite mats drive multipotent and pluripotent stem cell osteogenic differentation 40
Neural Stem Cells in a murine model of GM2-gangliosidosis: functional characterization and evaluation of their therapeutic potential 37
Lysosomal glycoidrolases activities in dendritic cells: is it a function of hematopoietic stem cells differentiation process? 37
Nitric Oxide Depletion Alter Hematopoietic Stem Cell Commitment Toward Immunogenic Dendritic Cell 36
Mouse sulphamidase gene: characterization of the promoter region of the gene and expression in mouse tissues 35
Stem cells and biomaterial interactions for neural tissue engineering models: A matter of mechanotransduction 35
Stem cells, nanocomposites and three dimensional muscle structures 35
Nanopatterned a-C:H forces hBM-MSCs Neural-mechanotransduction. 34
Hidrogenated amorphous carbon nanogrooves induce neuronal cells differentiation from human bone marrow-mesenchymal stem cells 34
Hexosaminidase and brain development: improvement for GM2 gangliosidosis therapy 34
miR128 up-regulation correlates with impaired Amyloid-β42 degradation in monocytes of patients with sporadic Alzheimer’s disease 34
Phatophysiology studies improve the effectiveness of a therapeutic approach to Tay-Sachs disease 33
Hexosaminidase expression during brain development and neural stem cells differentiation in GM2-gangliosidosis 33
Triggering Osteogenesis in Adult and Induced Pluripotent Stem Cells by Nanocomposite Scaffold 32
Promoters characterization of the gene coding for mouse and bovine di-N-acetylchitobiase 31
Implication of Cathepsin S and D, and of the Lysosomal Cysteine Protease Inhibitor Cystatin C during TPO+IL-16-Induced Generation of Tolerogenic Dendritic Cells from Hematopoietic Stem Cells 31
Regulation of neural stem cell compartments in a murine model of GM2-gangliosidosis: potential role of EGF and GM3 ganglioside 31
The Hex B gene is up-regulated during the brain development: effect for GM2 gangliosidosis therapy 30
Effect of Amorphous Carbon Nano-patterns on Human Bone Marrow Stromal Stem Cells 30
Pathophysiology analysis improves the effectiveness of Tay-Sachs disease therapy 30
Generation of neural cells from bone marrow stromal-stem cells and human dental stem cells: a comparative study 30
Knockdown of HEX genes generate a tolerogenic-like dendritic cells phenotype 29
Lysosomal glycohydrolases activities enhancement in dendritic cells is a function of hematopietic stem cells differentiation 29
Silencing of HEXA and HEXB genes reveals a role of beta-hexosaminidase in neuroinflammation 29
Lysosomal aspartic protease cathepsin D processing as a novel biomarker for hematopietic stem cells 29
Relevance of cathepsin S and D expression for the generation of tolerogenic dendritic cells from hematopoietic stem cells 28
Totale 3.901
Categoria #
all - tutte 14.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020550 67 28 77 6 73 53 64 25 80 36 7 34
2020/2021735 5 64 16 61 223 20 66 3 72 12 75 118
2021/2022601 6 147 30 24 27 5 4 179 5 10 75 89
2022/20231.018 85 138 22 66 84 116 1 47 412 0 36 11
2023/2024531 55 43 29 5 6 0 95 32 103 14 49 100
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 3.901